Çağdaş Kalkan

Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 study

Cihan Yurdaydın, Onur Keskın, Çağdaş Kalkan et al. · Hepatology · 2017 · 151 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

Cihan Yurdaydın, Onur Keskın, Çağdaş Kalkan et al. · The Journal of Infectious Diseases · 2018 · 92 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

Cihan Yurdaydın, Onur Keskın, Esra Yurdcu et al. · Hepatology · 2021 · 77 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

Çağdaş Kalkan, M.F. Karakaya, Esra Yurdcu et al. · Journal of Hepatology · 2017 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Assessment of Gastric Emptying in Patients with Autoimmune Gastritis

Çağdaş Kalkan, İrfan Soykan, Çiğdem Soydal et al. · Digestive Diseases and Sciences · 2016 · 33 citations

Medicine, Immunology, Internal Medicine +14